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ABSTRACT
Background: Researchers have determined that Indians face a higher risk of heart disease, despite the fact that 
nearly half of them are vegetarians and lack many of the other traditional risk factors. In the below-30 age group, 
coronary artery disease mortality among Indians is three-fold higher than in the whites in United Kingdom and 
ten-fold higher than the Chinese in Singapore. High levels of homocysteine have been widely linked to the early 
onset of heart diseases in other populations, although a definite proof among Indians is lacking, which needs to be 
investigated by way of screening for factors responsible for high homocysteine levels. Objective: To screen for 
genetic factors responsible for hyperhomocysteinemia and the risk for premature coronary artery disease. Materials 
and Methods: A total of 100 individuals with proven premature coronary artery disease and 200 age-and-sex matched 
controls were screened for polymorphisms in Methylenetetrahydrofolate reductase (MTHFR) (C677T) Methionine 
synthase (MS) genes (A2756G, C2758G), and the B12 and Folate levels were estimated. Results: Results from the 
mutational analysis revealed that in the study group, seven individuals had a polymorphism for the C677T allele 
in the MTHFR gene (one homozygous and six heterozygous) (Fischer’s Exact test P > 0.046) (OR: 0.2711 95% 
CI 0.0774 to 0.9491). Six were heterozygous for the A2756G polymorphism in the MS gene (Fischer’s Exact test  
P > 0.0012). None showed a polymorphism at the C2758G allele in the MS gene. Four controls showed heterozygosity 
for the C677T polymorphism and none for the MS gene. The B12 and Folate levels were significantly lower in 
the study group as compared to the controls. Conclusions: It is important to know which factors determine the 
total homocysteine concentrations. In the general population, the most important modifiable determinants of tHcy 
are folate intake and coffee consumption. Smoking and alcohol consumption are also associated with the total 
homocysteine concentrations, but more research is necessary to elucidate whether these relations are not originating 
from residual confounding due to other lifestyle factors.
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INTRODUCTION
Indians have the highest rate of heart disease, usually 
two-to-three times higher than the Americans, Europeans 
and Japanese, according to a study.[1] About 25% of heart 
attacks among men and women of Indian descent occur 
when they are younger than 40. This is unheard of in 
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other populations. In a significant study, in view of the 
propensity of Indians for heart diseases, scientists have 
recorded high levels of homocysteine, which is emerging 
as an ‘independent risk factor’. The elevated levels of this 
compound, homocysteine, may add to the already existing 
high risk factors.[2] High levels of homocysteine have been 
widely linked to early onset of heart diseases in other 
populations, although a definite proof among Indians   
is lacking, which needs to be investigated by way of 
screening for factors responsible for high homocysteine 
levels.[3]
Cardiovascular disease remains the major cause of 
morbidity and death in developed countries. The major 
classic risk factors like diabetes, hypertension, and the like, 
and non-modifiable risk factors such as age, sex, and family 
history cannot fully explain why some individuals are prone 
to coronary artery disease and others are not. Pathological 
and epidemiological studies suggest that only about one-
half to two-thirds of the variation in anatomic extent of 
atherosclerosis and risk for atherosclerotic vascular disease 
can be explained by the classic risk factors. Therefore, 
many emerging risk factors have been investigated, 
and among these, elevated plasma homocysteine levels 
(hyperhomocysteinemia) is of particular interest. Recent 
epidemiological studies have shown that moderately 
elevated plasma homocysteine levels are highly prevalent 
in the general population and are associated with an 
increased risk for fatal and non-fatal cardiovascular disease, 
independent of classic cardiovascular risk factors.
Within the last decade, homocysteine has arguably attracted 
more attention from biochemists than any other amino 
acid. Homocysteine is a sulfur-containing amino acid 
produced during the metabolism of the essential amino 
acid methionine. On account of this, homocysteine may 
be renewed into methionine. It may also be converted into 
either cysteine or taurine, via transsulfuration. If specific 
cofactors are lacking, homocysteine may not be converted 
into any beneficial compounds within the body. 
Homocysteine is toxic in nature and the accumulation (or 
build up) of this amino acid will often result in plasma 
toxicity. Various epidemiological studies indicate that this 
homocysteine toxicity, in concurrence with genetic and 
dietary factors, accounts for the elevated risks of coronary 
heart disease, stroke, and peripheral vascular disease.[4]
Hyperhomocysteinemia is an independent risk factor 
for cardiovascular disease. Although there is a growing 
body of evidence that homocysteine plays a causal role in 
atherogenesis, specific mechanisms to explain the underlying 
pathology have remained elusive. 
Homocysteine (Hcy) is a sulfhydryl-containing amino acid, 
formed during the metabolism of methionine, found in 
abundance in proteins of animal origin. Homocysteine 
is metabolized via remethylation or transsulfuration, and 
there are two alternate pathways of remethylation in 
humans. The predominant vitamin B12-dependent re-
synthesis of methionine from Hcy occurs in all human 
tissues and comprises of the transfer of the methyl 
group during the conversion of 5-methyltetrahydrofolate 
to tetrahydrofolate. Tetrahydrofolate binds the carbon 
unit from serine to nitrogen N5 and N10 forming 
5,10-methylenetetrahydrofolate that is later converted 
to 5-methly tetrahydrofolate in the reaction catalyzed by 
the 5,10-MTHFR. An additional remethylation reaction 
of minor physiological importance requires the presence 
of betaine as the methyl group donor and betaine-
homocysteine methyl transferase as a catalyzing enzyme. 
In the transsulfuration pathway Hcy combines with serine 
forming cystathione in a vitamin-dependent reaction, 
catalyzed by cystathione beta-synthase (CBS). Cystathione 
is later hydrolyzed to cysteine and alpha-ketobutyrate in the 
reaction catalyzed by gamma-cystathionase, with pyridoxal 
phosphate as a cofactor. Cysteine is eventually metabolized 
to taurine and sulfates.[5]
It is well-accepted that the elevated blood levels of 
homocysteine (hyperhomocysteinemia) increase the risk 
of cardiovascular disease. High homocysteine is a strong 
predictor for cardiovascular events and is a risk factor for 
mortality in patients with coronary artery disease.[6,7]
The understanding of homocysteine-induced vascular 
dysfunction is still incomplete from a mechanistic point of 
view. Homocysteine may alter the normally anti-coagulant 
phenotype of blood vessels to a pro-coagulant phenotype, 
along with the activation of platelets. In homocystinurics 
with severe hyperhomocysteinemia, this leads to premature 
thromboembolism. The movement of monocytes into 
the neo-intima may be stimulated by the homocysteine-
induced expression of the monocyte chemoattractant 
protein 1 (MCP-1) in the endothelium. Homocysteine 
may also be mitogenic to smooth muscle cells that invade 
the neo-intima of the developing lesion. Recent studies 
suggest that hyperhomocysteinemia in humans and 
animals cause endothelial dysfunction, which results in 
impaired relaxation of the blood vessels. Although the 
mechanism is still not clear, many of these studies suggest 
that homocysteine limits the bioavailability of endothelial-
derived nitric oxide, a potent vasodilator. The limited 
bioavailability of nitric oxide may be due to the ability of 
homocysteine to generate reactive oxygen species, and 
hence, oxidative stress.[8] 158 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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Factors that determine plasma Hcy levels can be genetic 
or environmental. The former include a rare cystathionine 
beta-synthase (CBS) deficiency and homozygous forms of 
the MTHFR C677T mutation. A vascular event occurs in 
half of the untreated patients, of less than 30 years.
The MTHFR gene is located on chromosome 1 at 1p 36.3. 
The cDNA sequence is 2.2 kilo bases long and appears to 
consist of 11 exons.[9] The C677T allele is a single base 
pair mutation in which a cytosine is converted to thymine 
at basepair 677, resulting in an amino acid substitution 
of alanine to valine, in the enzyme.[10,11] The molecular 
genetics of the mutation have been recently reviewed. 
Functionally, the encoded protein has a reduced protein 
activity at 37 degrees[12] and higher, so the C677T mutation 
is often termed ‘thermolabile’. For instance, compared to 
the controls treated similarly, samples from the C677T 
homozygotes have 50 - 60% lower MTHFR activity at 37°C 
and about 65% lower activity at 46°C. Heterozygotes are 
in the intermediate range. 
Methionine synthase, one of the B12-dependent mammalian 
enzymes, catalyzes the remethylation of homocysteine 
to methionine and the concurrent demethylation of 
5-methylenetetrahydrofolate to tetrahydrofolate. Under 
conditions of B12-depletion, such as pernicious anemia, 
loss of the methione synthase activity leads to a ‘methyl 
folate trap’. The depletion of other folate coenzymes 
result in defective DNA synthesis and the development 
of megablastic anemia. Of late homocysteine has received 
considerable attention as elevations in plasma homocysteine 
have been implicated as a risk factor for vascular disease.[13]
The methionine synthase gene is located on chromosome 
1q43, producing methionine and tetrahydrofolate. The 
gene coding for MS has common polymorphic forms 
(A2756G, D919G, and C2758G H920D). The base 
transition, converting an aspartic acid into glycine, occurs 
near the crucial vitamin B12 binding site, and therefore, 
might influence the enzyme secondary structure with 
possible functional consequences.[14] The present study 
was undertaken to screen SNP’s of MTHFR, MS genes 
and levels of vitamin B12 and Folate in individuals with   
premature coronary artery disease from India. 
MATERIALS AND METHODS
A total of 100 individuals with proven premature 
cardiovascular disease, that is, individuals with myocardial 
infarction or angina, below 45 years of age, who were non-
hypertensive, non-diabetic, and with normal lipid profiles, 
and 200 age- and sex-matched controls were studied for 
the stated polymorphisms. Blood was collected from 
the individuals with prior informed written consent and 
was used for polymorphism and biochemical analyses. 
Peripheral blood was collected in 5-mL EDTA container 
for isolation of genomic DNA. The white blood cells were 
isolated from the collected blood samples using erythrocyte 
lysis buffer. Cells were incubated at 55°C for 2 hours with 
20 mg/mL proteinase K and 20% sodium lauryl sulphate. 
The cells were added to 5 mL phenol (Tris saturated, 
pH 8) and centrifuged at 10,000rpm for 10 minutes. The 
supernatant was collected and 5 mL phenol-chloroform-
isoamyl alcohol (25:24:1) was added and centrifuged at 
10,000g for 10 minutes. To the collected supernatant,   
5 mL chloroform was added and centrifuged at 10,000rpm. 
Absolute alcohol was added to the supernatant to 
precipitate the DNA. The DNA was dissolved in 150 μL 
Millipore water and stored at −20°C.
C677T mutational analysis of the Methylene tetrahydrofolate 
reductase (MTHFR) gene was carried out by the method of 
Frosst et al., 1995. The primers used were Forward Primer: 
5` TGA AGG AGA AGG TGT CTG CGG GA 3` and 
Reverse Primer: 5` AGG ACG GTG CGG TGA GAG TG 
3`. A2756G mutational analysis of the Methionine synthase 
(MS) gene was carried out by the method of D. Leclerc   
et al, using Forward Primer: 5`CAT GGA AGA ATA TGA 
AGA TAT TAG AC 3` and Reverse Primer: 5`GAA CTA 
GAA GAC AGA AAT TCT CTA 3`. C2758G mutational 
analysis of the Methionine synthase (MS) gene was carried 
out by the method of Leclerc et al., (1996), using Forward 
Primer: 5` TGA AGG AGA AGG TGT CTG CGG GA 
3` and Reverse Primer: 5`AGG ACG GTG CGG TGA 
GAG TG 3`. The concentration of the primers used was 
20 pmoles, 10 mM of dNTPs, 1 unit of Taq enzyme, 10X 
concentration of Taq buffer, and 200 ng of template DNA. 
Thermal cycling conditions for C677T MTHFR were 
95°C for five minutes and 95°C for one minute, 59°C for 
one minute and 72°C for two minutes, followed by 72°C 
for seven minutes, for a total of 35 cycles, which yielded 
a product size of 198 bp. Thermal cycling conditions for 
A2756G and C2758G MS were 95°C for five minutes and 
95°C for one minute, 61°C for one minute, 72°C for two 
minutes, followed by 72°C for seven minutes for a total of 
35 cycles, which yielded a product size of 189 bp. 
The MTHFR mutation creates a Hinf I restriction site at 
677 position in the gene. The polymerase chain reaction 
(PCR) products were subjected to restriction digestion 
using 5 units of the Hinf I restriction enzyme at 37oC 
for 12 hours. Homozygote C677T yielded 175 bp; 23 bp, 
the heterozygote 198 bp, 175 bp, and 23 bp, and the wild 159 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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type yielded 198 bp. The methionine synthase A2756G 
mutation created a Hae III restriction site at the 2756 
position in the gene. The PCR products were subjected 
to restriction digestion using five units of BsuRI, an 
isoschizomer of the Hae III restriction enzyme, at 37oC 
for 12 hours. Homozygote A2756G yielded 150 bp;   
39 bp, the heterozygote yielded 189 bp, 150 bp, and 39 bp, 
and the wild type yielded 189 bp. The methionine synthase 
C2758G mutation abolished the Sau96I restriction site 
at 2758 position in the gene. The PCR products were 
subjected to restriction digestion using five units of Cfr13I, 
an isoschizomer of the Sau96 I restriction enzyme, at 37oC 
for three hours. The homozygote C2758G yielded 189 bp, 
the heterozygote yielded 189 bp, 150 bp, and 39 bp, and 
the wild type yielded 150 bp, 39 bp. All the products were 
resolved on 2% agarose gel.
Estimation of serum B12 levels
Estimation of serum vitamin B12 levels was done using 
a competitive protein binding chemiluminescent assay.
(IMMULITE; Diagnostic Products Corporation). 
The serum was diluted with Vitamin B12 sample diluent. 
Two hundred microliters of the diluted serum sample 
or standard were added to the prepared tubes, as also   
1000 µl working solution (Borate KCN buffer solution 
and Dithiothreitol Solution), and it was vortexed. All the 
test tubes were loosely capped and placed in a covered, 
boiling water bath for 15 - 20 minutes. The tubes were 
removed from the boiling water bath, and cooled in an 
ambient water bath for five minutes. Three hundred and 
fifty microliters of the treated sample was added to the each 
IMMULITE sample cup, and incubated for 30 minutes at 
37°C, with intermittent agitation. During this incubation, 
an alkaline phosphatase-labeled, anti-hog intrinsic factor 
was introduced and the test unit incubated at 28oC for a 30 
minute cycle. The unbound enzyme conjugate was removed 
with the help of a centrifugal wash. The intensity of color 
was monitored, to estimate B12.
Estimation of serum folic acid levels
The serum samples were diluted with the folic acid diluent 
and 200 µl of sample was added to each prepared tube 
containing 1000µl of the working solution (Borate KCN 
buffer solution, ligand labeled folate, and Dithiothreitol 
Solution). All test tubes were loosely capped and placed 
in a covered, boiling water bath for 15 - 20 minutes. The 
tubes were removed from the boiling water bath, and 
cooled in an ambient water bath for five minutes. Three 
hundred and fifty microliters of the treated sample, ligand 
labeled folic acid, and folic acid binding protein were 
simultaneously introduced into the each IMMULITE 
sample cup, and incubated for 30 minutes at 37 0C, with 
intermittent agitation. The intensity of color was monitored 
to estimate folate.
Statistical analysis
Statistical analyses were performed using Fischer’s Exact 
test and Odd’s ratio, P < 0.05 was considered statistically 
significant. 
RESULTS
The mean age of the individuals was found to be   
37.85 ± 6.01 years (age range 23 - 45) and that of the 
controls was 38.7 ± 5.25 years (age range 22 - 45 years). 
Of the 100 individuals that comprised the study group, 
10 (10 %) were of highly mobile group, and the majority 
comprised of the sedentary category, which was found 
to be 90 (90 %). Of the 100 individuals, the majority had 
anterior wall MI incidence, 63 (63%), followed by the 
other categories like angina, nine (9%), Inferior wall MI, 
nine (9%), posterior wall MI, nine (9%), lateral wall MI, 
nine (9%), and LV dysfunction one (1%). The majority of 
the study group comprised of individuals from the urban 
populace, 75 (75 %), and 25 (25 %) individuals were from 
the rural background. Of the 100 individuals 48 (48%) 
were smokers, none were obese, 16 (16%) consumed 
oral tobacco of different kinds (Gutka, Zarda, etc.), 45 
(45 %) were alcoholics, and a majority of 75 (75 %) were   
non-vegetarians. The majority in the study group were found 
not to consume fruits and salads. Only five (5 %) were found 
to consume fruits and salads out of the 100 that comprised 
the study group. Of the 100 individuals five individuals   
(5 %) had a history of consanguinity [Table 1]. The 
Mean ± SD of homocysteine was 36.80 ± 14.69 
in the patients and 16.25 ± 12.30 in the controls, 
serum triglycerides were found to be 143.18 ± 66.02 
in the patients and 140.25 ± 68.05 in the controls. 
Cholesterol was 158.13 ± 28.62 in the patients and   
150.10 ± 30.2 in the controls, HDL was 38.5 ± 5.86 in the 
patients and 38.9 ± 6.16 in the controls, and the LDL was 
found to be 101.66 ± 26.39 in the patients and 109.5 ± 7.15 
in the controls [Table 2]. The Mean ± SD of B12 levels 
in the affected individuals was 467 ± 127.8 pg/ml and it 
was 545.04 ± 171.8 pg/ml in the controls, and the Folate 
levels were 7.50 ± 2.0 ng/ml in the affected individuals 
and 11.85 ± 2.7 ng/ml in the controls [Table 3].160 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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Figure 1: Representative photograph showing RFLP analysis of the MTHFR 
C677T gene using Hinf I. Wild type gives a single band at 198 bp. Homozygosity 
for the variant yields two fragments of 175 bp and 23 bp. The 23 bp is 
undetectable in 2% agarose gel. Lane 1: Marker lane; Lane 2,3 - Wild type; 
Lane 4 - PCR product (198 bp), Lane 5: Homozygous variant
Figure 2: Representative photograph showing RFLP analysis of the MTHFR 
C677T gene using Hinf I. Wild type gives a single band at 198 bp. Heterozygosity 
for the variant yields three fragments of 198 bp, 175 bp, and 23 bp. The 23 bp 
is undetectable in 2% agarose gel. Lane 1. Marker lane; Lane 2- PCR Product 
(198bp); Lane 3,4, 6-8- Wild type (198bp), Lane 5: Heterozygous variant
Figure 3: Representative photograph showing RFLP analysis of MS A2756G 
gene using BsuRI and MS C2758G gene using Cfr13I. Wild type for 2756 
variant yields a single band of 189 bp, heterozygote yields three bands of 189 
bp, 150 bp, and 39 bp. The homozygote yields two bands of 150 bp and 39 
bp. Wild type for 2758 yields two fragments of 150 bp and 39 bp, heterozygote 
yields three fragments of 189 bp, 150 bp, and 39 bp, and the homozygote yields 
an intact band of 189 bp. Lane 1: Marker lane, Lanes 2 and 3: Normal 2758 
allele (150 bp), Lane 4 and 6: Heterozygote for 2756 allele, Lane 5: Normal for 
2756 allele, and Lane 7: PCR product (189 bp)
Table 1: Clinical and relevant data of individuals with 
pre-CAD and controls
Pre-CAD (n = 100) Control (n = 200)
Age (years) 37.85±6.01 years 38.7±5.25 years
[age range 23-45] [age range 22-45]
Inferior wall MI 9 (9) -
Posterior wall MI 9 (9) -
Anterior wall MI 63 (63) -
Lateral wall MI 9 (9) -
Angina 9 (9) -
LV dysfunction 1 (1) -
Vegetarians 25 (25) 40 (20)
Non-vegetarians 75 (75) 160 (80)
Lifestyle (Sedentary) 90 (90) 160 (80)
Urban 75 (75) 170 (85)
Smokers 48 (48) -
Alcoholics 45 (45) -
Obese 0 (0) -
Salads None -
Fruits 5 (5) -
Consanguinity 5 (5) -
MI: Myocardial infarction, LV: Left ventricle, Figures in parenthesis ( ) are in 
percentage
Table 2: Biochemical data of individuals with pre-CAD 
and controls
Study group  
n = 100
Control group  
n = 200
Homocysteine 36.80±14.69 16.25±12.30 
Serum triglycerides 143.18±66.02 140.25±68.05
Cholesterol 158.13±28.62 150.10±30.2
HDL 38.5±5.86 38.9±6.16
LDL 101.66±26.39 109.5±7.15
HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein, Data represented 
as Mean±SD
Table 3: B12 levels in individuals with pre-CAD and 
controls
Groups Number of 
cases
Serum B12 (Pg /ml)
Mean±SD
Study group 100 467 ± 127.8
Control group 200 545.04±171.8
Seven patients showed 677C→T mutation; restriction 
fragment length polymorphism (RFLP) analysis revealed   
one was Homozygous for TT [Figure 1] and six were 
heterozygous [Figure 2] for CT. Four of the 200 controls 
revealed CT (heterozygous) polymorphism (Fischer’s 
Exact test P < 0.046) (OR: 0.2711 95% CI 0.0774 to 
0.9491). Six patients showed 2756A→G mutation 
[Figure 3], RFLP analysis revealed Heterozygosity in all 
the six (Fischer’s Exact test P > 0.0012). None of the 
controls revealed the stated polymorphism. None of the 
100 individuals or 200 controls had shown this variant 
2758C→G in the MS gene [Figure 3]. 161 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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DISCUSSION
Cardiovascular disease is the leading cause of death in 
developed and developing countries. A person’s genetic 
makeup, reflected by his or her family history, may influence 
the risk of various forms of cardiovascular disease. 
Although classic Mendelian patterns of inheritance have 
been observed for certain less common cardiovascular 
disorders, more common diseases, such as atherosclerotic 
disease, have atypical patterns of inheritance and a 
multifactorial pathogenesis. It is a difficult challenge to 
relate the study of the genetic basis of complex causes of 
common cardiovascular disease, such as atherosclerosis.[14]
Hyperhomocysteinemia is an independent risk factor 
for cardiovascular disease. There is growing evidence 
that homocysteine plays a causal role in atherogenesis. 
Homocysteine is a sulfhydryl-containing amino acid, 
formed during the metabolism of methionine, found in 
abundance in proteins of animal origin. Homocysteine 
is metabolized via the remethylation or transulfuration. 
The predominant Vitamin-B12-dependent resynthesis 
of methionine from homocysteine occurs in human 
tissues and comprises the transfer of the methyl group 
during the conversion of 5-methyltetrahydrofolate to 
tetrahydrofolate. Tetrahydrofolate binds to the carbon 
unit from serine to the nitrogen N5 and N10, forming 
5,10-methylenetetrahydrofolate in the reaction catalyzed 
by 5,10-methylenetetrahydro folate reductase (MTHFR).[5]
The non-significant relationship between the C677T 
MTHFR polymorphism and CVD observed in this study 
does not contradict the homocysteine theory, because 
of the genetic and nutrient interactions. The C677T 
polymorphism may predict CVD risk only in certain ethnic 
groups[15] and the significant association of polymorphisms 
in the MTHFR gene has not been observed in this group. 
The difference in the frequency of the C677T polymorphism 
in the MTHFR in different populations, suggests that in the 
past, the mutation had the advantage of selection. It has 
been suggested that in times of famine, reduced MTHFR 
activity led to decreased remethylation of homocyeteine 
and thus preserved the available one-carbon moieties of 
the tetrahydrofolate metabolism for the vital synthesis of 
purines and thymidine.[16-18] 
A review on the role of nutritional supplementation in 
reducing the levels of homocysteine, had suggested that in 
the Indian population, apart from low dietary folate intake, 
the intake of riboflavin, vitamin B12, and vitamin B6 are also 
low when compared with the Western population.[19] Other 
studies[20,21] that mentioned the ‘Indian dietary paradox’, 
which has assumed that many Indians, by virtue of their 
vegetarian diet, do receive fairly adequate amounts of folate 
and explained the paradox for this as prolonged cooking, 
heating, frying of vegetables, which is a common practice 
among Indian households, and can destroy up to 90% of 
the folate content in the vegetables. This assumption could 
probably explain the low frequency of polymorphisms seen 
in the present study. 
There is no significant association between C677T 
polymorphism and CAD[22] (OR: 0.2711 95% CI 0.0774 to 
0.9491) [Table 4]. There is a higher frequency of T alleles in 
females than in males,[23] and the present study comprised of 
all males, below the age of 45 years. The MTHFR C677T 
mutation, identified as a major determinant of homocysteine 
concentrations in Europeans, is less prevalent and does not 
influence homocysteine concentrations in South Asians.[24] A 
clear association exists between tHcy-levels, but not between 
C677T in the MTHFR and the two polymorphisms in MS 
and CAD, as stated by Rothenbacher et al.[25] 
Methionine synthase (5-methyltetrahydrofolate 
homocysteine methyl transferase) catalyzes the re-
methylation of homocysteine to methionine in a reaction 
wherein methylcobalamin serves as the intermediate methyl 
carrier. This occurs by transfer of the methyl group of 
5-methyl tetrahydrofolate to the enzyme bound cob(I)
alamin, which forms methylcobalamin, with subsequent 
transfer of the methyl group to the homocysteine, to 
form methionine. Over time cob(I)alamin may become 
oxidized to cob(II)alamin, reducing the enzyme and making 
it inactive. Regeneration of the functional enzyme occurs 
through methionine synthase mediated methylation of the 
cob(II) alamin in which S-adenosyl methionine is used as a 
methyl donor. Deficiency of methionine synthase activity 
results in hyperhomocysteinemia. 
Two polymorphisms namely 2756 A→G (D919G) and 
2758 C→G (H920D) have been identified in the MS gene. 
The two identified polymorphisms cause cblG disease and 
are located in the vicinity of the cobalimin-binding domain. 
Table 4: Frequency of different genotypes in individuals 
with pre-CAD and controls
MTHFR MS Fischer’s 
value
C677T A 2756G C 2758G
Pre-
CAD
6 
(heterozygote)
6  
(heterozygote)
0 MTHFR:  
P >0.046
(n=100) 1(homozygote) MS:  
P >0.0012
MTHFR (OR: 0.2711 95%CI 0.0774 to 0.9491)
Controls
(n=200)
4 
(heterozygote)
0 0162 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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H920D substitution is found in a region that is in the α 
helix at the C-terminal, and a region in the α/β domain, 
and the genetic variants of methionine synthase may 
lead to mild hyperhomocysteinemia, with a consequent 
impact on cardiovascular disease. Although, in the present 
study, a low frequency (six heterozygotes), A2756G 
polymorphism was observed; it was significantly associated 
with hyperhomocysteinemia, as the polymorphisms were 
seen in hyperhomocysteinemic individuals and not in 
individuals with normal homocysteine levels. The other 
polymorphism C2758G has not been observed in the 
study group and it can be concluded by the present study 
that it is not a risk factor in the Indian population.[26] 
Vitamin B(12) and folate deficiency, reflected by increased 
Methylmalonic Acid (MMA) concentration, is an 
important risk factor both for the development of 
hyperhomocysteinemia and CAD.[27] The B12 levels were 
significantly lower (467 ± 127.8 pg / ml) in the study 
group as compared to the control group (545.04 ± 171.8) 
[Table 3] and the folate levels were also significantly lower 
in the study group (7.50 ± 2.0 ng / ml) as compared to the 
control group (11.85 ± 2.7) [Table 5].
Studies have shown an inverse association between fruit, 
vegetable, and fiber consumption and the risk for coronary 
artery disease. Majority of the individuals in the study 
group rarely consumed fruits or vegetables [Table 1], which 
not only reduced the risk for coronary artery disease, but 
was also known to quench the free radicals.[28] The free 
radical nitric oxide levels in the present study group were 
significantly raised compared to those in the controls, the 
study was published elsewhere.[29]
According to a recent study, both cigarette smoking 
and coffee consumption were associated with increased 
homocysteine levels.[30] In the present study both smoking and 
caffeine consumption was significantly high and seems to be 
associated with an increased risk of cardiovascular disease.
Majority of the individuals in the present study had 
sedentary lifestyles (90 % Table 1). Prospective studies 
strongly support the view that a sedentary lifestyle is 
associated with an increased risk of CAD.[31] Adopting a 
lifestyle that includes moderate physical activity in middle 
age appears to have a beneficial effect on that risk, with a 
reduction in total and LDL cholesterol and a concomitant 
increase in HDL cholesterol.[32] All the Biochemical 
Parameters like LDL, HDL, and Cholesterol were normal 
in the study group [Table 2].
A significant increase in homocysteine levels among 
patients with CAD was seen with every additional risk 
factor. For the risk factors that were considered refer to 
Table 6. A majority (92%) of the individuals who comprised 
the study group had more that three associated additional 
risk factors, as stated by Abraham et al.[33]
It is important to know which factors determine the total 
homocysteine concentrations, as it seems to be a significant 
risk factor for CAD. In the general population, the most 
important modifiable determinants of tHcy are folate 
intake and coffee consumption. Smoking and alcohol 
consumption are also associated with the total homocyeteine 
concentrations, but more research is necessary to elucidate 
whether these relations are not originating from residual 
confounding factors due to other lifestyle factors.
It is difficult to predict the usefulness of the increasing number 
of these polymorphisms in the manifestation of the disease, 
because the interaction of these genes with others would be 
difficult to establish, and it requires large population studies 
to sort out both the genetic and environmental interactions. 
It seems reasonable to have data on these polymorphisms in 
the clinical record as part of the investigation of coronary 
artery disease or of hyperhomocysteinemia. At this point, the 
presence or absence of a particular polymorphism in a gene 
of the homocysteine pathway is not a complete explanation 
of an individual phenotype for one of the most common 
multifactorial disease, such as the cardiovascular disease. As 
the genetics of atherosclerosis continues to evolve, these 
factors along with newer emerging factors may become a 
part of the routine assessment, aiding prediction of future 
coronary events.
To conclude, hyperhomocysteinemia is a risk factor for 
CAD, but not the polymorphisms in the studied genes 
Table 5: Serum folate in individuals with  
pre-CAD and controls
Groups Number of cases Serum total folate 
(ng /ml)
Study group 100 7.50±2.004
Control group 200 11.85±2.7
Data represented as Mean±SD
Table 6: Number of associated independent risk factors* 
for pre-CAD in individuals with hyperhomocystenemia
No. of 
associated 
independent 
risk factors
1 2 3 4 5
No. of 
individuals (%)
8 (8) 0 52 (52) 28 (28) 12 (12)
*Associated risk factors taken up: 1: Smoking,  2: Oral tobacco chewing, 
3: Coffee consumption, 4: Alcohol consumption, 5: Food habits (Non-vegetarian),   
6: Occupation status (sedentary lifestyles), None of the individuals in the study group 
had all the 6 associated risk factors. 163 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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in this study group, although many contributory factors 
namely low B12 and Folate levels are responsible for 
hyperhomocysteinemia. Low consumption of fruits and 
salads, sedentary lifestyles, smoking, and high levels of free 
radical nitric oxide are the other prominent risk factors for 
the causation of premature coronary artery disease. In the 
presence of mutations, either in the MTHFR or MS genes, 
there is a significant increase in homocysteine levels, so it 
would be useful to routinely genotype the polymorphisms 
in high-risk individuals. Adequate consumption of fruits 
and salads, foods fortified with B12 and folate, physical 
exercise, abstaining from smoking and consumption of 
tobacco products, is highly advised for a disease-free life.
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